Kalaris Therapeutics, Inc.
For the period ended Jan 9, 2025. Filed Dec 6, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jan 9, 2025 · Filed Dec 6, 2024
Use the contents to explore the available documents and sections.
KLRS$1.87-18.7%Stored close · as of Nov 10, 2026
Opening this filing…